Similar results were obtained with anti-Cenp B+ and anti-Topo-I+ sera compared to control sera and to SSc sera negative for anti-Cenp-B, anti-Topo-I antibodies and for other ENAs. This evidence concerns the gene CENPB and systemic sclerosis.